167 related articles for article (PubMed ID: 20814243)
1. The oncogenic role of the ETS transcription factors MEF and ERG.
Sashida G; Bazzoli E; Menendez S; Liu Y; Nimer SD
Cell Cycle; 2010 Sep; 9(17):3457-9. PubMed ID: 20814243
[TBL] [Abstract][Full Text] [Related]
2. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
3. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
4. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
[TBL] [Abstract][Full Text] [Related]
5. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.
Zong Y; Xin L; Goldstein AS; Lawson DA; Teitell MA; Witte ON
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12465-70. PubMed ID: 19592505
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.
Suico MA; Fukuda R; Miyakita R; Koyama K; Taura M; Shuto T; Kai H
J Biol Chem; 2014 Sep; 289(38):26143-26154. PubMed ID: 25081543
[TBL] [Abstract][Full Text] [Related]
7. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.
Paulo P; Ribeiro FR; Santos J; Mesquita D; Almeida M; Barros-Silva JD; Itkonen H; Henrique R; Jerónimo C; Sveen A; Mills IG; Skotheim RI; Lothe RA; Teixeira MR
Neoplasia; 2012 Jul; 14(7):600-11. PubMed ID: 22904677
[TBL] [Abstract][Full Text] [Related]
8. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?
Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Perner S; Wernert N
Mol Med Rep; 2012 Feb; 5(2):313-6. PubMed ID: 22038307
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.
Ando K; Tsushima H; Matsuo E; Horio K; Tominaga-Sato S; Imanishi D; Imaizumi Y; Iwanaga M; Itonaga H; Yoshida S; Hata T; Moriuchi R; Kiyoi H; Nimer S; Mano H; Naoe T; Tomonaga M; Miyazaki Y
J Biol Chem; 2013 Mar; 288(13):9457-67. PubMed ID: 23393136
[TBL] [Abstract][Full Text] [Related]
10. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
Reddy ES; Rao VN
Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
Simpson S; Woodworth CD; DiPaolo JA
Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
[TBL] [Abstract][Full Text] [Related]
12. ERG upregulation and related ETS transcription factors in prostate cancer.
Rostad K; Mannelqvist M; Halvorsen OJ; Oyan AM; Bø TH; Stordrange L; Olsen S; Haukaas SA; Lin B; Hood L; Jonassen I; Akslen LA; Kalland KH
Int J Oncol; 2007 Jan; 30(1):19-32. PubMed ID: 17143509
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia: a central role for the ETS factor ERG.
Martens JH
Int J Biochem Cell Biol; 2011 Oct; 43(10):1413-6. PubMed ID: 21664289
[TBL] [Abstract][Full Text] [Related]
14. MEF/ELF4 transactivation by E2F1 is inhibited by p53.
Taura M; Suico MA; Fukuda R; Koga T; Shuto T; Sato T; Morino-Koga S; Okada S; Kai H
Nucleic Acids Res; 2011 Jan; 39(1):76-88. PubMed ID: 20805247
[TBL] [Abstract][Full Text] [Related]
15. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Iljin K; Wolf M; Edgren H; Gupta S; Kilpinen S; Skotheim RI; Peltola M; Smit F; Verhaegh G; Schalken J; Nees M; Kallioniemi O
Cancer Res; 2006 Nov; 66(21):10242-6. PubMed ID: 17079440
[TBL] [Abstract][Full Text] [Related]
16. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acid residues in the ETS transcription factor Erg that mediate Erg-Jun/Fos-DNA ternary complex formation.
Verger A; Buisine E; Carrère S; Wintjens R; Flourens A; Coll J; Stéhelin D; Duterque-Coquillaud M
J Biol Chem; 2001 May; 276(20):17181-9. PubMed ID: 11278640
[TBL] [Abstract][Full Text] [Related]
18. Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia.
Tang JZ; Carmichael CL; Shi W; Metcalf D; Ng AP; Hyland CD; Jenkins NA; Copeland NG; Howell VM; Zhao ZJ; Smyth GK; Kile BT; Alexander WS
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6091-6. PubMed ID: 23533276
[TBL] [Abstract][Full Text] [Related]
19. The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.
Davidson B; Goldberg I; Tell L; Vigdorchik S; Baekelandt M; Berner A; Kristensen GB; Reich R; Kopolovic J
Clin Exp Metastasis; 2004; 21(3):191-9. PubMed ID: 15387369
[TBL] [Abstract][Full Text] [Related]
20. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
